At a glance
ClinicalIndex Comparison RecordPhase 3Completed· 19 enrolled
Drug / intervention
Fecal microbiota transplantationbiological
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Implications of Fecal Microbiota Transplantation in Modulating the Effects of Liver Cirrhosis
In Brief
A Phase 3 clinical trial evaluating Fecal microbiota transplantation for Liver Cirrhosis. Completed, enrolled 19 participants across 1 site.
Detailed Summary
The study aims to investigate the beneficial effects of fecal transplantation in patients diagnosed with liver cirrhosis (regardless of etiology).
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsLiver Cirrhosis
CountriesRomania
Collaborators--
Timeline
Phase 3CompletedFinished
20252026
First PostedJun 2024
Enrollment StartAug 2024
Primary CompletionDec 2024
Study CompletionMar 2025
TodayJul 2026
First PostedJun 27, 2024
Enrollment StartAug 5, 2024
Primary CompletionDec 30, 2024
Study CompletionMar 31, 2025
TodayJul 2, 2026
Enrollment to primary: 5 monthsPosted 2.0 years ago
Interventions
Fecal microbiota transplantationbiological
Performing a colonoscopy with fecal microbiota transplantation at the level of the cecum.